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Laggera pterodonta is a reputable ethnomedicinal plant in Nigeria for the treatment of pediatric malaria and inflammations.
The leaves, stem and root of Laggera Pterodonta (DC) Sch. Bip (compositae) were investigated for their phytochemical and
thin  layer  chromatographic  profiles.  Twelve  secondary  metabolites  namely  carbohydrates,  terpenes,  flavonoids,  phenols,
tannins, phlobatannins, sterols, alkaloids, volatile oil, balsams, reins and chlorogenic acid were detected in all the plant parts.
Carbohydrate and resin were present in the leaves. Saponins were present in the stem and root. Quantitative pharmacognostic
analysis of the leaves revealed moisture content of 9.57%, total ash of 19.45%, acid-insoluble ash of 2.35%, alcohol extractive
value  of  16.12%,  and water  extractive  value  of  27.75%.  Comparative  thin  layer  chromatography of  the  successive  cold
maceration and soxhlet extraction using solvents of increasing polarities: hexane, ethyl acetate and methanol of the leaves,
stem and root showed that soxhlet extraction yielded more components. This is the first report of the presence of alkaloids in
this plant.
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Introduction
The aerial part  of  Laggera pterodonta has been widely used in China  as a  folk medicine  for several centuries to
ameliorate some inflammatory ailments, arthritis, and hepatitis and as anti-viral agents (Yihang et al., 2007 and Shuyun et al.,
2007). In Nigeria the fresh aerial part of the plant is used for the treatment of pediatrics malaria. For this purpose the fresh
aerial part of the plant is pounded and water added, filtered and the filtrate is drunk and the residue is rubbed all over the body
(Muazzam Ibrahim, personal communication, 2009).
Laggera pterodonta (DC) Sch. Bip belonging to the family Asteraceae/Compositae is a robust herb that grows up to 1.70m
in height. It is viscid and strongly aromatic. It has white flowers, basal leaves bigger than the upper ones. It is a weed found in
open waste land and partially shaded galleried forest. It is a native of Africa and Asia. In Africa, it can be found in Senegal,
Sierra Leone, Nigeria and West Cameroon. In Nigeria, the Yorubas refer to it as ‘taba-agbe’, while the Hausas refer to it as
‘taba-taba’ because it resembles tobacco leaves (Burkill 2000).
Yihang et al. (2007) reported that the phenolics from Laggera pterodonta have hepatoprotective and anti-oxidant effects
on chemical-induced hepatic injury in neonatal rat hepatocytes.  L. pterodonta is also use as aromatic substances in cosmetics,
scents and incense (Burkill 2000). The main secondary metabolites isolated so far from L. pterodonta are sesquiterpenoids such
as eudesmanoic acids, flavonoids and phenolic acids of which Isochlorogenic acid is reputed. Pharmacological investigations
revealed that certain extracts of L. pterodonta possess significant anti-inflammatory, anti-tumor and anti-viral activities (Zhou
et al., 2008). Three bioactive compounds (Fig. 1): 3, 5-O-dicaffeoylquinic acid (1);  3, 4-O-dicaffeoylquinic acid (2) and 4,
5-O-dicaffeoylquinic (3) had been isolated from the aqueous extract of L. pterodonta. These compounds have been reported to
be responsible for the anti-viral, anti-bacterial and antifungal activities of the plant. The isolation and purification of these
compounds was achieved by high speed counter-current chromatography (HSCCC) method (Shuyun et al 2007). The principal
component of the phenolic content of L. pterodonta has been identified as Isochlorogenic acid which is responsible for its
hepatoprotective  and  anti-oxidative  effect.  This  may  support  the  folkloric  use  of  L.  pterodonta  in  the  treatment  of
inflammatory ailments, arthritis and hepatitis (Yihang et al., 2007).
Previous investigations on this plant  led to the  isolation of 55 eudesmane sesquiterpenes,  nine  flavonoids;  and eleven
compounds which comprises of terpenoids and flavonoids from the aerial part  of the plant  (Liu et  al.,  2008). The eleven
compounds  have  been  identified  as  6-O-beta-d-  glucopyranosyl-carvotanacetone,  pterodontic  acid  (3),  1-beta  hydroxyl
pterodontic  acid,  pterodontoside  A,  pterodontriol,  pterodotriol  B,  5-hydroxy-3,4׳,6,7-tetramethoxyflavone  (4),  armitin,
chrysosplenetin B, quercetin and beta-sitosterol. Reports revealed that pterodontic acid and pterodontriol showed moderate
activity against  bacteria  while  they both displayed no activity against  E.coli  (Guang-zhong,  et  al.,  2007).  Further  reports
revealed that three eudesmanoic acid (5) and two eudesmanoic acid glycosides were isolated from the n-butanol extracts of
whole plant of L.  pterodonta (Zhou -Yu et al., 1997). Chlorogenic acid (6) is the esterification product of quinic acid (7) and
(E)-3-(3, 4-dihydroxyphenyl)-prop-2-enoic acid (8).
In view of the rich medicinal uses of L. pterodonta coupled with its rich phytochemical profile, L. pterodonta no doubt is a
potential drug plant. The aim of this work therefore is to document the medicinal uses of L. pterodonta and to evaluate its
secondary metabolites constituents and quantitative pharmacognostical characteristics that could be useful for the development
of a monograph on this plant. 
Materials and Methods
The Plant was collected from Life Camp Abuja, Nigeria. The plant was identified and authenticated at the herbarium of the
National Institute for Pharmaceutical Research and Development, Abuja, Nigeria, where the voucher specimen (NIPRD/H
/6298) was deposited.
Plant preparation: The plant was air-dried for two weeks. The leaves were dried at room temperature while the stem and
roots were sun-dried. The particle size of the various parts was reduced using a warring blender and the powdered samples
were stored in airtight polythene bags.
Phytochemical screening and quantitative pharmacognostical analysis: These were carried out using standard procedures
(MHFW 1990, Evans 2002, and Sofowora 2008).
Extraction and thin layer chromatography: Successive extractions with hexane, Ethylacetate and methanol were carried out
on the powdered samples of all the parts by cold maceration for 24 hours and soxhlet extraction using 1g and 10g sample
respectively. Each extract was spotted on a normal phase silica gel precoated glass plate previously activated at 1200C for 2
hours, developed using mobile phase hexane-ethyl acetate (3:1) for hexane and ethyl acetate extracts and hexane-ethyl acetate
-methanol (35:15:1) for methanol extracts.
Results and Discussion
Phytochemical  screening  of  the  leaf,  stem  and  root  of  Laggera  Pterodonta  (Table  1)  revealed  twelve  secondary
metabolites namely carbohydrates, terpenes, flavonoids, phenols, tannins, phlobatannins, sterols, alkaloids, volatile oil, resins,
balsams and chlorogenic acid, collectively in all the plant parts. Carbohydrates were present only in the leaves. Saponins were
present only in the stem and root. The presence of these secondary metabolites suggests that L. pterodonta might be of great
importance in phytomedicine development. For instance, the presence of flavonoids and resins might be responsible for the use
of  this  plant  to  ameliorate  inflammatory  ailments  in  China.  Yihang et  al.,  (2007)  reported  that  the  flavonoids  from L.
pterodonta had anti-inflammatory effect on both acute and chronic-inflammation.
The presence of phenols may confer anti-oxidative, antibacterial and anti-viral effects as reported earlier (Yihang et al.,
2007, Shuyun et al., 2007 and Wasagu et al., 2005). The presence of alkaloids, tannins and saponins in the plant suggests that it
might possess anti-bacterial activity. Favel et al., (1994) as well as Isaac and Chinwe (2001) reported that alkaloids along
tannins and saponins are responsible for anti-bacterial activity in Fetracarpidium Conopheoum. Onoruvwe and Olorunfeni
(1998)  also  attributed  the  anti-bacterial  effect  of  the  root  extract  of  Dcibrostachys  cinerea  to  alkaloids,  saponins  and
flavoniods. The presence of tannins could also mean that it is an astringent, with wound healing and anti-parasitic properties.
Presence of volatile oil in all the parts suggests its use in natural body cosmetic and scents. The presence of terpenes could
suggest that L. pterodonta of Nigeria origin might have anti-tumor and antibacterial activities since as reported by Guang-zhong
et al 2007 eudesmane sesquiterpenes isolated from L. pterodonta displayed cytotoxicity toward tumor cells and possessed
anti-bacterial properties.
The  quantitative  pharmacognostic  analysis  of  the  leaves  revealed  moisture  content  of  9.57%,  total  ash  of  19.45%,
acid-insoluble ash of 2.35%, alcohol extractive value of 16.12%, and water extractive value of 27.75% as shown in Table 2.
Low moisture content of 9.57% implies that, the plant has low chance of microbial attack hence can be stored in the dried form
as a drug plant for a long period of time. Ash value of 19.45% value indicates that it has high inorganic content this may be due
to the presence of high non-physiological ash. Hence, when processing this plant as a drug it should be rinsed sufficiently in
clean water before drying to remove sand. Acid-insoluble ash value of 2.35% is indicative high digestibility of the plant when
consumed. Water extractive value of 27.72% which is greater than the alcohol extractive value of 16.12% means water will be
a better solvent for extraction of the plant. This may explain why in Nigeria the fresh aerial part of the plant is used for the
treatment of pediatrics malaria by pounding, mixing it with water, filtering and drinking the filtrate.
The successive cold maceration and soxhlet extraction using solvents of increasing polarities: hexane, ethyl acetate and
methanol of  the  leaves,  stem and  root  showed  that  soxhlet  extraction  yielded  more  components  for  all  the  plant  parts
investigated compared to cold maceration. Hence soxhlet extraction would be a better method of extraction of this plant as
shown in Table 3. Components on the chromatogram were detected using various visualization techniques such as viewing
under daylight (D), ultraviolet light 365 nm (UV) and placement in iodine vapor tank. The visualization technique that revealed
each component in the chromatogram is indicated in table 3 above. Chemical component with Rf 0.65 visible under daylight
and iodine vapor as well as Rf 1.00 are common to the leaf, stem and root.
In conclusion, the indigenous knowledge on L. pterodonta shows that in Nigeria aerial part of the plant is reputable for the
treatment  of  pediatrics malaria.  The  analyses carried out  on this plant  shows that  L.  pterodonta  from Nigerians’  rich  in
secondary metabolites which could be explored as potential drug leads and phytomedicines. This study revealed for the first
time the presence of alkaloids in L. pterodonta. Further studies are on-going in our laboratories to isolate and characterize the
alkaloids in L. pterodonta from Nigeria, investigate their biological properties and to verify the antimalarial properties of the
plant.
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Fig.1. Bioactive compounds of L. pterodonta.












Tannins + + +
Saponins - + +Key:   + = Detected;     - = Not detected
  





Alcohol extractive value 16.12
Water extractive value 27.75
 
Table 3. Retardation factors (Rf values) of components in hexane, ethyl acetate and methanol extracts of L.
pterodonta leaf.
















LH1 0.33(D)        
LH2 0.61(D)        
LE1 0.70(D)        
LE2 0.08(D) 0.26(D) 0.33(D) 0.46(D) 0.53(D) 0.65(DI) 0.73(D) 1.00(I)
SH1 0.65(DI)        
SH2 0.11(I) 0.65(DI) 0.76(D) 0.80(D) 0.88(D) 1.00(I)   
SE1 0.65(DI)        
SE2 0.61 (I) 0.65(DI) 0.83(UV)      
RH1 0.61(I) 0.65(DI) 0.75(D) 0.81(UV) 0.95(D)    
RH2 0.60(D) 0.65(DI) 0.71(D) 0.76(D) 0.81(UV) 0.90(D) 1.00(I)  
RE1 0.08(D) 0.65(DI)       
RE2 0.65(DI)        
ME O.37(D) 0.54(D) 0.74(D) 0.87(D)     
 
Key:   LH1 = cold maceration Leaf hexane extract;      LH2 = soxhlet Leaf hexane extract.   
     LE1 = cold maceration Leaf ethyl acetate extract; LE2 = soxhlet Leaf ethyl acetate extract.  
           SH1 = cold maceration Stem hexane extract;   SH2 = soxhlet Stem hexane extract.      
SE1 = cold maceration Stem ethyl acetate extract; SE2 = soxhlet Stem ethyl acetate extract.
           RH1 = cold maceration Root hexane extract;    RH2 = soxhlet Root hexane extract.
 RE1 = cold maceration Root ethyl acetate extract; RE2 = soxhlet Root ethyl acetate extract.
ME = cold maceration Leaf methanol extract UV = visible under ultraviolet light 365 nm;
D = visible under Daylight; I = visible under iodine vapor; and (DI) = visible under daylight and
 iodine vapor. Mobile phase solvent system used are: hexane-ethyl acetate (3:1) for hexane and
 ethyl acetate extracts; and hexane-ethyl acetate -methanol (35:15:1) for methanol extracts.
 
 
